Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.

Moritz S, Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, Köther U, Woodward TS, Treszl A, Menon M, Schneider BC, Pfueller U, Roesch-Ely D.

JAMA Psychiatry. 2014 Oct;71(10):1103-11. doi: 10.1001/jamapsychiatry.2014.1038.

PMID:
25103718
2.

Increasing stimulus duration can normalize late-positive event related potentials in people with schizophrenia: Possible implications for understanding cognitive deficits.

Wexler BE, Ikezawa S, Corbera S.

Schizophr Res. 2014 Sep;158(1-3):163-9. doi: 10.1016/j.schres.2014.07.012. Epub 2014 Aug 3.

PMID:
25096541
3.

Phenotypic characteristics in metabolically healthy but obese patients with schizophrenia.

Sheng J, Li C, Wang J, Chiang C, Harrington A, Yi Z, Liu D, Fan X.

Psychiatry Res. 2014 Dec 15;220(1-2):71-5. doi: 10.1016/j.psychres.2014.07.015. Epub 2014 Jul 16.

PMID:
25086765
4.

High rates of obstructive sleep apnea symptoms among patients with schizophrenia.

Annamalai A, Palmese LB, Chwastiak LA, Srihari VH, Tek C.

Psychosomatics. 2015 Jan-Feb;56(1):59-66. doi: 10.1016/j.psym.2014.02.009. Epub 2014 Mar 2.

PMID:
25023923
5.

Psychological therapies for auditory hallucinations (voices): current status and key directions for future research.

Thomas N, Hayward M, Peters E, van der Gaag M, Bentall RP, Jenner J, Strauss C, Sommer IE, Johns LC, Varese F, García-Montes JM, Waters F, Dodgson G, McCarthy-Jones S.

Schizophr Bull. 2014 Jul;40 Suppl 4:S202-12. doi: 10.1093/schbul/sbu037. Review.

6.

Is living with psychosis demoralizing? Insight, self-stigma, and clinical outcome among people with schizophrenia across 1 year.

Cavelti M, Rüsch N, Vauth R.

J Nerv Ment Dis. 2014 Jul;202(7):521-9. doi: 10.1097/NMD.0000000000000160.

PMID:
24933416
7.

Implementation of treatment guidelines for specialist mental health care.

Barbui C, Girlanda F, Ay E, Cipriani A, Becker T, Koesters M.

Cochrane Database Syst Rev. 2014 Jan 17;1:CD009780. doi: 10.1002/14651858.CD009780.pub2. Review.

PMID:
24443146
8.

The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.

Lerner V, Miodownik C, Gibel A, Sirota P, Bush I, Elliot H, Benatov R, Ritsner MS.

J Clin Psychiatry. 2013 Dec;74(12):1224-32. doi: 10.4088/JCP.12m08160.

PMID:
24434091
9.

Community adherence to schizophrenia treatment and safety monitoring guidelines.

Keller WR, Fischer BA, McMahon R, Meyer W, Blake M, Buchanan RW.

J Nerv Ment Dis. 2014 Jan;202(1):6-12. doi: 10.1097/NMD.0000000000000093.

10.

Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.

Garcia-Portilla MP, Garcia-Alvarez L, Saiz PA, Diaz-Mesa E, Galvan G, Sarramea F, Garcia-Blanco J, Elizagarate E, Bobes J.

Int J Environ Res Public Health. 2013 Dec 24;11(1):373-89. doi: 10.3390/ijerph110100373.

11.

The CANSAS self-report for screening of needs in outpatients with schizophrenia and schizoaffective disorders.

Ponizovsky AM, Rothstein I, Grinshpoon A.

Community Ment Health J. 2014 Apr;50(3):343-7. doi: 10.1007/s10597-013-9677-4. Epub 2013 Dec 12.

PMID:
24337474
12.

Quality of care in psychosis and bipolar disorder from the service user perspective.

Skelly N, Schnittger RI, Butterly L, Frorath C, Morgan C, McLoughlin DM, Fearon P.

Qual Health Res. 2013 Dec;23(12):1672-85. doi: 10.1177/1049732313509896. Epub 2013 Oct 25.

PMID:
24163347
13.

The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity.

Rausch F, Eifler S, Esser A, Esslinger C, Schirmbeck F, Meyer-Lindenberg A, Zink M.

Compr Psychiatry. 2013 Oct;54(7):1068-76. doi: 10.1016/j.comppsych.2013.04.016. Epub 2013 Jun 4.

PMID:
23759152
14.

Hypnosedative prescribing in outpatient psychiatry.

Huthwaite MA, Andersson V, Stanley J, Romans SE.

Int Clin Psychopharmacol. 2013 Jul;28(4):157-63. doi: 10.1097/YIC.0b013e32836248f1.

PMID:
23680995
15.

Symptom severity scale of the DSM5 for schizophrenia, and other psychotic disorders: diagnostic validity and clinical feasibility.

Ritsner MS, Mar M, Arbitman M, Grinshpoon A.

Psychiatry Res. 2013 Jun 30;208(1):1-8. doi: 10.1016/j.psychres.2013.02.029. Epub 2013 Apr 10.

PMID:
23582209
16.

A prevalence study of urinary tract infections in acute relapse of schizophrenia.

Miller BJ, Graham KL, Bodenheimer CM, Culpepper NH, Waller JL, Buckley PF.

J Clin Psychiatry. 2013 Mar;74(3):271-7. doi: 10.4088/JCP.12m08050.

PMID:
23561234
17.

Prevalence of psychoses in Stockholm County--a population-based study using comprehensive healthcare registers.

Jörgensen L, Allebeck P, Dalman C.

Nord J Psychiatry. 2014 Jan;68(1):60-5. doi: 10.3109/08039488.2013.772234. Epub 2013 Mar 11.

PMID:
23472654
18.

Yoga-based intervention for caregivers of outpatients with psychosis: a randomized controlled pilot study.

Varambally S, Vidyendaran S, Sajjanar M, Thirthalli J, Hamza A, Nagendra HR, Gangadhar BN.

Asian J Psychiatr. 2013 Apr;6(2):141-5. doi: 10.1016/j.ajp.2012.09.017. Epub 2012 Nov 23.

PMID:
23466111
19.

Cognitive Behavioral Therapy for negative symptoms (CBT-n) in psychotic disorders: a pilot study.

Staring AB, Ter Huurne MA, van der Gaag M.

J Behav Ther Exp Psychiatry. 2013 Sep;44(3):300-6. doi: 10.1016/j.jbtep.2013.01.004. Epub 2013 Feb 1.

PMID:
23454550
20.

WAIS-IV profile of cognition in schizophrenia.

Michel NM, Goldberg JO, Heinrichs RW, Miles AA, Ammari N, McDermid Vaz S.

Assessment. 2013 Aug;20(4):462-73. doi: 10.1177/1073191113478153. Epub 2013 Feb 26.

PMID:
23443820
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk